Literatur
-
1
ACC/AHA
Task Force on Practice Guidelines .
ACC/AHA
guidelines for the evaluation and management of chronic heart failure
in the adult: Executive summary.
Circulation.
2001;
104
2996-3007
-
2
Acute Infarction Ramipril
Efficacy (AIRE) Study Investigators .
Effects of ramipril
on mortality and morbidity of survivors of acute myocardial infarction
with clinical evidence of heart failure.
Lancet.
1993;
342
821-828
-
3
Avorn J, Soumerai S B.
Improving drug
therapy decision through educational outreach.
N Engl
J Med.
1983;
308
1457-1463
-
4
Barron H V, Michaels A D, Maynard C, Every N R.
Use of angiotensin-converting
enzyme inhibitors at discharge in patients with acute myocardial
infarction in the United States: Data from the National Registry
of Myocardial Infarction 2.
J Am Coll Cardiol.
1998;
32
360-367
-
5
Beers M H, Dang J, Hasegawa J, Tamai I Y.
Influence of
hospitalization on drug therapy in the elderly.
J Am Geriatr
Soc.
1989;
37
679-683
-
6
Berbatis C G, Maher M J, Plumbridge R J, Stoehlwinder J U, Zubrick S R.
Impact of a drug
bulletin on prescribing oral analgesics in a teaching hospital.
Am
J Hosp Pharm.
1982;
38
98-100
-
7
Chin M H, Friedmann P D, Cassel C K, Lang R M.
Differences
in generalist and specialist physicians` knowledge and
use of angiotensin-converting enzyme inhibitors for congestive heart
failure.
J Gen Intern Med.
1997;
12
523-530
-
8
Classen D C, Pestotnik S L, Evans R S, Lloyd J F, Burke J P.
Adverse drug events in hopspitalized
patients: excess length of stay, extra costs, and attributable mortality.
J
Am Med Assoc.
1997;
277
301-306
-
9
Cohn J N, Johnsons G, Zeische S, Cobb F, Francis G, Tristani F, Smith R, Dunkman W B, Loeb H, Wong M, Bhat G, Goldman S, Fletcher R D, Doherty J, Hughes V, Carson P, Cintron G, Shabetai R, Haakenson C.
A comparison
of enalapril with hydralazine-isosorbide dinitrate in the treatment
of chronic congestive heart failure.
N Engl J Med.
1991;
325
303-310
-
10
EUROASPIRE Study Group .
EUROASPIRE:
a European Society of Cardiology survey of secondary prevention
of coronary heart disease, principal results.
Eur Heart
J.
1997;
18
1569-1582
-
11
Goettler M, Schneeweiss S, Hasford J.
Adverse
drug reaction monitoring - cost and benefit consideration
part II: Cost and preventability of adverse drug reactions leading
to hospital admission.
Pharmacoepidemiol Drug Saf.
1997;
6
79-90
(Suppl 3)
-
12
Greer A L.
The
state of the art versus the state of the science.
Int
J Technol Assess Health Care.
1988;
4
5-26
-
13
Grimshaw J M, Russell J T.
Effect of
clinical guidelines on medical practice: a systematic review of
rigorous evaluations.
Lancet.
1993;
342
1317-1322
-
14
Grimshaw J M, Russell J T.
Achieving
health gain through clinical guidelines. II. Ensuring that guidelines
change medical practice.
Qual Health Care.
1994;
3
45-52
-
15
Haines A, Feder G.
Guidance on guidelines.
Writing them is easier than making them work.
BMJ.
1992;
305
785-786
-
16
Hobbs F DR, Jones M I, Allan T F, Wison S, Tobias R.
European
survey of primary care physician perceptions on heart failure diagnosis
and management (Euro-HF).
Eur Heart J.
2000;
21
1877-1887
-
17
Hoppe U C, Erdmann E. für
die Kommission für Klinische Kardiologie, Deutsche Gesellschaft
für Kardiologie - Herz- und Kreislaufforschung .
Leitlinien
zur Therapie der chronischen Herzinsuffizienz.
Z Kardiol.
2001;
90
218-241
-
18
Jassim Al Khaja K A, Sequeira R P, Mathur V S.
Rational pharmacotherapy of hypertension
in the elderly: analysis of the choice and dosage of drugs.
J
Clin Pharm Ther.
2001;
26
33-42
-
19
Kober L, Torp-Pedersen C, Carlsen J E, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole D S, Auclert L, Pauly N C, Aliot E, Persson S, Camm A J.
A
clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril
in patients with left ventricular dysfunction after myocardial infarction.
N
Engl J Med.
1995;
333
1670-1676
-
20
Köhler G I, Bode-Böger S M, Busse R, Hoopmann M, Welte T, Böger R H.
Drug-drug interactions in medical patients:
Effects of in-hospital treatment and relation to multiple drug use.
Int
J Clin Pharmacol Ther.
2000;
38
504-513
-
21
Lazarou J, Pomeranz B H, Corey P H.
Incidence of adverse drug reactions in hospitalized
patients: a meta-analysis of prospective studies.
J Am
Med Assoc.
1998;
279
1200-1205
-
22
Levy M, Kewitz H, Altwein W, Hillebrand J, Aliakim M.
Hospital
admissions due to adverse drug reactions: A comparative study from
Jerusalem and Berlin.
Eur J Clin Pharmacol.
1980;
17
25-31
-
23
Lomas J, Anderson G M, Domnick-Pierre K, Vayda E, Enkin M W, Hannah W J.
Do
practice guidelines guide practice?.
N Engl J Med.
1989;
321
1306-1311
-
24
Pfeffer M A, Pfeffer J M, Steinberg C, Finn P.
Survival after an experimental
myocardial infarction: beneficial effects of long-term therapy with
captopril.
Circulation.
1985;
72
406-412
-
25
Popplewell P Y, Henschke P J.
Acute admissions
to a geriatric assessment unit.
Med J Aust.
1982;
1
343-344
-
26
Rahmahi T M, Longo M D, Rohlfs K, Sheynberg N.
Effect of heart failure program
on cardiovascular drug utilization and dosage in patients with chronic
heart failure.
Clin Cardiol.
2000;
23
909-914
-
27
Remme W J, Swedberg K. for the Task Force for
the Diagnosis and treatment of Chronic Heart Failure, European Society
of Cardiology .
Guidelines for the diagnosis and treatment
of chronic heart failure.
Eur Heart J.
2001;
22
1527-1560
-
28
Schaffner W, Ray W A, Federspiel C F, Miller W O.
Improving
antibiotic prescribing in office practice.
J Am Med Assoc.
1983;
250
1728-1732
-
29
Siegel D.
The
influence of national guidelines on antihypertensive prescribing
patterns.
Curr Hypertens Rep.
2000;
2
247-252
-
30
SOLVD Investigators .
Effect
of enalapril on survival in patients with reduced left ventricular
ejection fractions and congestive heart failure.
N Engl
J Med.
1991;
325
293-302
-
31
Teweleit S, Kuschel U, Hippius M, Goettler M, Bornschein B.
Manifestation
und Präventionsmöglichkeiten unerwünschter
Arzneimittelwirkungen (UAW) in der Pharmakotherapie von Herz- Kreislauferkrankungen.
Med
Klin.
2001;
96
442-450
-
32
van Veldhuisen D J, Charlesworth A, Crijns H JGM, Lie K I, Hampton J R.
Differences
in drug treatment of chronic heart failure between European countries.
Eur
Heart J.
1999;
20
666-672
-
33
Wagdi P, Vuilliomenet A, Kaufmann U, Richter M, Bertel O.
Ungenügende
Behandlungsdisziplin, Patienteninformation und Medikamentenverschreibung
als Ursachen für die Notfallhospitalisation bei chronisch
herzinsuffizienten Patienten.
Schweiz Med Wschr.
1993;
123
198-112
-
34
Williamson J, Chopin J M.
Adverse reactions
to prescribed drugs in the elderly: A multicentre investigation.
Age
Ageing.
1980;
9
73-90
Prof. Dr. med. Rainer H. Böger
Arbeitsgruppe Klinische Pharmakologie, Institut
für Experimentelle und Klinische Pharmakologie und Toxikologie, Universitätsklinikum
Hamburg-Eppendorf
Martinistraße 52
20246
Hamburg
Phone: 040/428039759
Fax: 040/428039757
Email: boeger@uke.uni-hamburg.de
